FDA-Drug2026-10-21Class IIPACKAGING DEFECT
Teva Metoclopramide 5 mg tablets recalled for foreign tablets or capsules in bottles
Nationwide distributionDrugs
What this means
Teva Pharmaceuticals discovered that some bottles of Metoclopramide 5 mg tablets contain foreign tablets or capsules mixed in with the correct medication. The contamination was found in specific lots distributed nationwide. No injuries have been reported.
- Check your Metoclopramide 5 mg bottle for lot numbers 8634085, 8635085, 8636085 (100-tablet bottles) or lot 8633085 (500-tablet bottles), all expiring 07/2027.
- If your bottle matches these lot numbers, do not use it and contact your pharmacy or Teva Pharmaceuticals immediately.
- Do not discard the medication without instructions from your pharmacy or poison control.
The agency's original wording
Hazard
Presence of Foreign Tablets/Capsules
Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide.
Affected count
240,448 cartons
Manufactured in
400 Interpace Pkwy Bldg A, Parsippany, NJ, United States
Products
Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0038-2027More Teva recalls
- FDA-Drug2026-09-09Teva trazodone 50 mg tablets recalled for foreign tablets in bottles
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.